Artículos de revistas
Peripheral P2x7 Receptor-induced Mechanical Hyperalgesia Is Mediated By Bradykinin
Registro en:
Neuroscience. Elsevier Ltd, v. 277, n. , p. 163 - 173, 2014.
3064522
10.1016/j.neuroscience.2014.06.057
2-s2.0-84904871792
Autor
Teixeira J.M.
de Oliveira-Fusaro M.C.G.
Parada C.A.
Tambeli C.H.
Institución
Resumen
P2X7 receptors play an important role in inflammatory hyperalgesia, but the mechanisms involved in their hyperalgesic role are not completely understood. In this study, we hypothesized that P2X7 receptor activation induces mechanical hyperalgesia via the inflammatory mediators bradykinin, sympathomimetic amines, prostaglandin E2 (PGE2), and pro-inflammatory cytokines and via neutrophil migration in rats. We found that 2'(3')-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate triethylammonium salt (BzATP), the most potent P2X7 receptor agonist available, induced a dose-dependent mechanical hyperalgesia that was blocked by the P2X7 receptor-selective antagonist A-438079 but unaffected by the P2X1,3,2/3 receptor antagonist TNP-ATP. These findings confirm that, although BzATP also acts at both P2X1 and P2X3 receptors, BzATP-induced hyperalgesia was mediated only by P2X7 receptor activation. Co-administration of selective antagonists of bradykinin B1 (Des-Arg8-Leu9-BK (DALBK)) or B2 receptors (bradyzide), β1 (atenolol) or β2 adrenoceptors (ICI 118,551), or local pre-treatment with the cyclooxygenase inhibitor indomethacin or the nonspecific selectin inhibitor fucoidan each significantly reduced BzATP-induced mechanical hyperalgesia in the rat hind paw. BzATP also induced the release of the pro-inflammatory cytokines tumor necrosis factor α (TNF-α), interleukin (IL)-1β, IL-6 and cytokine-induced neutrophil chemoattractant-1 (CINC-1), an effect that was significantly reduced by A-438079. Co-administration of DALBK or bradyzide with BzATP significantly reduced BzATP-induced IL-1β and CINC-1 release. These results indicate that peripheral P2X7 receptor activation induces mechanical hyperalgesia via inflammatory mediators, especially bradykinin, which may contribute to pro-inflammatory cytokine release. These pro-inflammatory cytokines in turn may mediate the contributions of PGE2, sympathomimetic amines and neutrophil migration to the mechanical hyperalgesia induced by local P2X7 receptor activation. © 2014. 277
163 173 Allibardi, S., Merati, G., Chierchia, S., Samaja, M., Atenolol depresses post-ischaemic recovery in the isolated rat heart (1999) Pharmacol Res, 39, pp. 431-435 Barrett, A.M., The pharmacology of atenolol (1977) Postgrad Med J, 53 (SUPPL. 3), pp. 58-64 Baumann, H., Gauldie, J., The acute phase response (1994) Immunol Today, 15, pp. 74-80 Beigi, R., Kobatake, E., Aizawa, M., Dubyak, G.R., Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase (1999) Am J Physiol, 276, pp. C267-C278 Belichard, P., Landry, M., Faye, P., Bachvarov, D.R., Bouthillier, J., Pruneau, D., Marceau, F., Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat: effect of kinin receptor antagonists (2000) Immunopharmacology, 46, pp. 139-147 Bianchi, B.R., Lynch, K.J., Touma, E., Niforatos, W., Burgard, E.C., Alexander, K.M., Park, H.S., van Biesen, T., Pharmacological characterization of recombinant human and rat P2X receptor subtypes (1999) Eur J Pharmacol, 376, pp. 127-138 Bilski, A.J., Halliday, S.E., Fitzgerald, J.D., Wale, J.L., The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551) (1983) J Cardiovasc Pharmacol, 5, pp. 430-437 Bryan, M.C., Biswas, K., Peterkin, T.A., Rzasa, R.M., Arik, L., Lehto, S.G., Sun, H., Allen, J.R., Chromenones as potent bradykinin B1 antagonists (2012) Bioorg Med Chem Lett, 22, pp. 619-622 Buell, G., Collo, G., Rassendren, F., P2X receptors: an emerging channel family (1996) Eur J Neurosci, 8, pp. 2221-2228 Burgess, G.M., Perkins, M.N., Rang, H.P., Campbell, E.A., Brown, M.C., McIntyre, P., Urban, L., Bloomfield, G.C., Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia (2000) Br J Pharmacol, 129, pp. 77-86 Calixto, J.B., Cabrini, D.A., Ferreira, J., Campos, M.M., Kinins in pain and inflammation (2000) Pain, 87, pp. 1-5 Campwala, H., Fountain, S.J., Constitutive and agonist stimulated ATP secretion in leukocytes (2013) Commun Integr Biol, 6, pp. e23631 Carreira, E.U., Carregaro, V., Teixeira, M.M., Moriconi, A., Aramini, A., Verri, W.A., Ferreira, S.H., Cunha, T.M., Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain (2013) Eur J Pain, 17, pp. 654-663 Chakfe, Y., Seguin, R., Antel, J.P., Morissette, C., Malo, D., Henderson, D., Seguela, P., ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels (2002) J Neurosci, 22, pp. 3061-3069 Cherkas, P.S., Dostrovsky, J.O., Sessle, B.J., Activation of peripheral P2X receptors is sufficient to induce central sensitization in rat medullary dorsal horn nociceptive neurons (2012) Neurosci Lett, 526, pp. 160-163 Chessell, I.P., Hatcher, J.P., Bountra, C., Michel, A.D., Hughes, J.P., Green, P., Egerton, J., Buell, G.N., Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain (2005) Pain, 114, pp. 386-396 Chiozzi, P., Sanz, J.M., Ferrari, D., Falzoni, S., Aleotti, A., Buell, G.N., Collo, G., Di Virgilio, F., Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor (1997) J Cell Biol, 138, pp. 697-706 Choy, E., Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis (2012) Rheumatology, 51 (SUPPL 5), pp. v3-v11 Clark, A.K., Staniland, A.A., Marchand, F., Kaan, T.K., McMahon, S.B., Malcangio, M., P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide (2010) J Neurosci, 30, pp. 573-582 Collo, G., Neidhart, S., Kawashima, E., Kosco-Vilbois, M., North, R.A., Buell, G., Tissue distribution of the P2X7 receptor (1997) Neuropharmacology, 36, pp. 1277-1283 Colomar, A., Marty, V., Medina, C., Combe, C., Parnet, P., Amedee, T., Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors (2003) J Biol Chem, 278, pp. 30732-30740 Costello, A.H., Hargreaves, K.M., Suppression of carrageenan-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist (1989) Eur J Pharmacol, 171, pp. 259-263 Couture, R., Harrisson, M., Vianna, R.M., Cloutier, F., Kinin receptors in pain and inflammation (2001) Eur J Pharmacol, 429, pp. 161-176 Cunha, F.Q., Lorenzetti, B.B., Poole, S., Ferreira, S.H., Interleukin-8 as a mediator of sympathetic pain (1991) Br J Pharmacol, 104, pp. 765-767 Cunha, F.Q., Poole, S., Lorenzetti, B.B., Ferreira, S.H., The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia (1992) Br J Pharmacol, 107, pp. 660-664 Cunha, T.M., Verri, W.A., Schivo, I.R., Napimoga, M.H., Parada, C.A., Poole, S., Teixeira, M.M., Cunha, F.Q., Crucial role of neutrophils in the development of mechanical inflammatory hypernociception (2008) J Leukoc Biol, 83, pp. 824-832 de Oliveira Fusaro, M.C., Pelegrini-da-Silva, A., Araldi, D., Parada, C.A., Tambeli, C.H., P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE(2) or dopamine (2010) Eur J Pharmacol, 649, pp. 177-182 Dell'Antonio, G., Quattrini, A., Cin, E.D., Fulgenzi, A., Ferrero, M.E., Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP (2002) Arthritis Rheum, 46, pp. 3378-3385 Dell'Antonio, G., Quattrini, A., Dal Cin, E., Fulgenzi, A., Ferrero, M.E., Antinociceptive effect of a new P(2Z)/P2X7 antagonist, oxidized ATP, in arthritic rats (2002) Neurosci Lett, 327, pp. 87-90 Dubyak, G.R., el-Moatassim, C., Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides (1993) Am J Physiol, 265, pp. C577-C606 Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi-Castagnoli, P., Di Virgilio, F., Mouse microglial cells express a plasma membrane pore gated by extracellular ATP (1996) J Immunol, 156, pp. 1531-1539 Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Collo, G., Buell, G., Di Virgilio, F., ATP-mediated cytotoxicity in microglial cells (1997) Neuropharmacology, 36, pp. 1295-1301 Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Melchiorri, L., Baricordi, O.R., Di Virgilio, F., Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages (1997) J Immunol, 159, pp. 1451-1458 Ferreira, S.H., Lorenzetti, B.B., Cunha, F.Q., Poole, S., Bradykinin release of TNF-alpha plays a key role in the development of inflammatory hyperalgesia (1993) Agents Actions, 38. , Spec No:C7-9 Ferreira, S.H., Lorenzetti, B.B., Poole, S., Bradykinin initiates cytokine-mediated inflammatory hyperalgesia (1993) Br J Pharmacol, 110, pp. 1227-1231 Ferreira, J., Campos, M.M., Pesquero, J.B., Araujo, R.C., Bader, M., Calixto, J.B., Evidence for the participation of kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice (2001) Neuropharmacology, 41, pp. 1006-1012 Ferreira, J., Triches, K.M., Medeiros, R., Cabrini, D.A., Mori, M.A., Pesquero, J.B., Bader, M., Calixto, J.B., The role of kinin B1 receptors in the nociception produced by peripheral protein kinase C activation in mice (2008) Neuropharmacology, 54, pp. 597-604 Filippini, A., Taffs, R.E., Agui, T., Sitkovsky, M.V., Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP (1990) J Biol Chem, 265, pp. 334-340 Fox, A., Wotherspoon, G., McNair, K., Hudson, L., Patel, S., Gentry, C., Winter, J., Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia (2003) Pain, 104, pp. 683-691 Fulgenzi, A., Dell'Antonio, G., Foglieni, C., Dal Cin, E., Ticozzi, P., Franzone, J.S., Ferrero, M.E., Inhibition of chemokine expression in rat inflamed paws by systemic use of the antihyperalgesic oxidized ATP (2005) BMC Immunol, 6, p. 18 Fulgenzi, A., Ticozzi, P., Gabel, C.A., Dell Antonio, G., Quattrini, A., Franzone, J.S., Ferrero, M.E., Periodate oxidized ATP (OATP) reduces hyperalgesia in mice: involvement of P2X7 receptors and implications for therapy (2008) Int J Immunopathol Pharmacol, 21, pp. 61-71 Galli, S.J., Kalesnikoff, J., Grimbaldeston, M.A., Piliponsky, A.M., Williams, C.M., Tsai, M., Mast cells as "tunable" effector and immunoregulatory cells: recent advances (2005) Annu Rev Immunol, 23, pp. 749-786 Gold, M.S., Shuster, M.J., Levine, J.D., Role of a Ca(2+)-dependent slow after hyperpolarization in prostaglandin E2-induced sensitization of cultured rat sensory neurons (1996) Neurosci Lett, 205, pp. 161-164 Gomis, A., Meini, S., Miralles, A., Valenti, C., Giuliani, S., Belmonte, C., Maggi, C.A., Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant (2013) Osteoarthritis Cartilage, 21, pp. 1346-1354 Gourine, A.V., Poputnikov, D.M., Zhernosek, N., Melenchuk, E.V., Gerstberger, R., Spyer, K.M., Gourine, V.N., P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats (2005) Br J Pharmacol, 146, pp. 139-145 Greig, A.V., Linge, C., Terenghi, G., McGrouther, D.A., Burnstock, G., Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes (2003) J Invest Dermatol, 120, pp. 1007-1015 Hide, I., Tanaka, M., Inoue, A., Nakajima, K., Kohsaka, S., Inoue, K., Nakata, Y., Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia (2000) J Neurochem, 75, pp. 965-972 Honore, P., Donnelly-Roberts, D., Namovic, M.T., Hsieh, G., Zhu, C.Z., Mikusa, J.P., Hernandez, G., Jarvis, M.F., A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino)methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl) acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat (2006) J Pharmacol Exp Ther, 319, pp. 1376-1385 Honore, P., Donnelly-Roberts, D., Namovic, M., Zhong, C., Wade, C., Chandran, P., Zhu, C., Jarvis, M.F., The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice (2009) Behav Brain Res, 204, pp. 77-81 Jacobson, K.A., Jarvis, M.F., Williams, M., Purine and pyrimidine (P2) receptors as drug targets (2002) J Med Chem, 45, pp. 4057-4093 Jain, N.K., Kulkarni, S.K., Singh, A., Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals (2001) Eur J Pharmacol, 423, pp. 85-92 Jarvis, M.F., Wismer, C.T., Schweitzer, E., Yu, H., van Biesen, T., Lynch, K.J., Burgard, E.C., Kowaluk, E.A., Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue (2001) Br J Pharmacol, 132, pp. 259-269 Kahlenberg, J.M., Dubyak, G.R., Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release (2004) Am J Physiol Cell Physiol, 286, pp. C1100-C1108 Khasar, S.G., McCarter, G., Levine, J.D., Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors (1999) J Neurophysiol, 81, pp. 1104-1112 Kim, M., Spelta, V., Sim, J., North, R.A., Surprenant, A., Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery (2001) J Biol Chem, 276, pp. 23262-23267 la Sala, A., Ferrari, D., Di Virgilio, F., Idzko, M., Norgauer, J., Girolomoni, G., Alerting and tuning the immune response by extracellular nucleotides (2003) J Leukoc Biol, 73, pp. 339-343 Ley, K., Linnemann, G., Meinen, M., Stoolman, L.M., Gaehtgens, P., Fucoidin, but not yeast polyphosphomannan PPME, inhibits leukocyte rolling in venules of the rat mesentery (1993) Blood, 81, pp. 177-185 Loram, L.C., Fuller, A., Fick, L.G., Cartmell, T., Poole, S., Mitchell, D., Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw (2007) J Pain, 8, pp. 127-136 Marceau, F., Hess, J.F., Bachvarov, D.R., The B1 receptors for kinins (1998) Pharmacol Rev, 50, pp. 357-386 McGaraughty, S., Chu, K.L., Namovic, M.T., Donnelly-Roberts, D.L., Harris, R.R., Zhang, X.F., Shieh, C.C., Jarvis, M.F., P2X7-related modulation of pathological nociception in rats (2007) Neuroscience, 146, pp. 1817-1828 Mingam, R., De Smedt, V., Amedee, T., Bluthe, R.M., Kelley, K.W., Dantzer, R., Laye, S., In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain (2008) Brain Behav Immun, 22, pp. 234-244 Mizumoto, N., Mummert, M.E., Shalhevet, D., Takashima, A., Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals (2003) J Invest Dermatol, 121, pp. 1066-1072 Neelands, T.R., Burgard, E.C., Uchic, M.E., McDonald, H.A., Niforatos, W., Faltynek, C.R., Lynch, K.J., Jarvis, M.F., 2', 3'-O-(2,4,6, trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor (2003) Br J Pharmacol, 140, pp. 202-210 Nelson, D.W., Gregg, R.J., Kort, M.E., Perez-Medrano, A., Voight, E.A., Wang, Y., Grayson, G., Carroll, W.A., Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists (2006) J Med Chem, 49, pp. 3659-3666 Oliveira, M.C., Pelegrini-da-Silva, A., Parada, C.A., Tambeli, C.H., 5-HT acts on nociceptive primary afferents through an indirect mechanism to induce hyperalgesia in the subcutaneous tissue (2007) Neuroscience, 145, pp. 708-714 Oliveira, M.C., Pelegrini-da-Silva, A., Tambeli, C.H., Parada, C.A., Peripheral mechanisms underlying the essential role of P2X3,2/3 receptors in the development of inflammatory hyperalgesia (2009) Pain, 141, pp. 127-134 Orita, T., Kimura, K., Nishida, T., Sonoda, K.H., Cytokine and chemokine secretion induced by poly (I:C) through NF-kappaB and phosphoinositide 3-kinase signaling pathways in human corneal fibroblasts (2013) Curr Eye Res, 38, pp. 53-59 Parada, C.A., Yeh, J.J., Joseph, E.K., Levine, J.D., Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat (2003) Eur J Neurosci, 17, pp. 1847-1852 Pastore, S., Mascia, F., Girolomoni, G., The contribution of keratinocytes to the pathogenesis of atopic dermatitis (2006) Eur J Dermatol, 16, pp. 125-131 Poole, S., Lorenzetti, B.B., Cunha, J.M., Cunha, F.Q., Ferreira, S.M., Bradykinin B1 and B2 receptors, tumor necrosis factor alpha and inflammatory hyperalgesia (1999) Br J Pharmacol, 126, pp. 649-656 Preobrazhenskaya, M.E., Berman, A.E., Mikhailov, V.I., Ushakova, N.A., Mazurov, A.V., Semenov, A.V., Usov, A.I., Bovin, N.V., Fucoidan inhibits leukocyte recruitment in a model peritoneal inflammation in rat and blocks interaction of P-selectin with its carbohydrate ligand (1997) Biochem Mol Biol Int, 43, pp. 443-451 Randall, L.O., Selitto, J.J., A method for measurement of analgesic activity on inflamed tissue (1957) Arch Int Pharmacodyn Ther, 111, pp. 409-419 Rosland, J.H., The formalin test in mice: the influence of ambient temperature (1991) Pain, 45, pp. 211-216 Rush, A.M., Waxman, S.G., PGE2 increases the tetrodotoxin-resistant Nav1.9 sodium current in mouse DRG neurons via G-proteins (2004) Brain Res, 1023, pp. 264-271 Safieh-Garabedian, B., Poole, S., Allchorne, A., Winter, J., Woolf, C.J., Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia (1995) Br J Pharmacol, 115, pp. 1265-1275 Sanz, J.M., Di Virgilio, F., Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells (2000) J Immunol, 164, pp. 4893-4898 Seyedi, N., Maruyama, R., Levi, R., Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norepinephrine release? (1999) J Pharmacol Exp Ther, 290, pp. 656-663 Shinoda, M., Ozaki, N., Asai, H., Nagamine, K., Sugiura, Y., Changes in P2X3 receptor expression in the trigeminal ganglion following monoarthritis of the temporomandibular joint in rats (2005) Pain, 116, pp. 42-51 Sikora, A., Liu, J., Brosnan, C., Buell, G., Chessel, I., Bloom, B.R., Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism (1999) J Immunol, 163, pp. 558-561 Solle, M., Labasi, J., Perregaux, D.G., Stam, E., Petrushova, N., Koller, B.H., Griffiths, R.J., Gabel, C.A., Altered cytokine production in mice lacking P2X(7) receptors (2001) J Biol Chem, 276, pp. 125-132 Spengler, R.N., Allen, R.M., Remick, D.G., Strieter, R.M., Kunkel, S.L., Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor (1990) J Immunol, 145, pp. 1430-1434 Summ, O., Evers, S., Mechanism of action of indomethacin in indomethacin-responsive headaches (2013) Curr Pain Headache Rep, 17, p. 327 Surprenant, A., North, R.A., Signaling at purinergic P2X receptors (2009) Annu Rev Physiol, 71, pp. 333-359 Taiwo, Y.O., Bjerknes, L.K., Goetzl, E.J., Levine, J.D., Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system (1989) Neuroscience, 32, pp. 577-580 Tambeli, C.H., Oliveira, M.C., Clemente, J.T., Pelegrini-da-Silva, A., Parada, C.A., A novel mechanism involved in 5-hydroxytryptamine-induced nociception: the indirect activation of primary afferents (2006) Neuroscience, 141, pp. 1517-1524 Teixeira, J.M., Oliveira, M.C., Nociti, F.H., Clemente-Napimoga, J.T., Pelegrini-da-Silva, A., Parada, C.A., Tambeli, C.H., Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats (2010) Eur J Pharmacol, 645, pp. 79-85 Teixeira, J.M., Oliveira, M.C., Parada, C.A., Tambeli, C.H., Peripheral mechanisms underlying the essential role of P2X7 receptors in the development of inflammatory hyperalgesia (2010) Eur J Pharmacol, 644, pp. 55-60 Theoharides, T.C., Alysandratos, K.D., Angelidou, A., Delivanis, D.A., Sismanopoulos, N., Zhang, B., Asadi, S., Kalogeromitros, D., Mast cells and inflammation (2012) Biochim Biophys Acta, 1822, pp. 21-33 Verri, W.A., Cunha, T.M., Parada, C.A., Poole, S., Cunha, F.Q., Ferreira, S.H., Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? (2006) Pharmacol Ther, 112, pp. 116-138 Wankowicz, Z., Megyeri, P., Issekutz, A., Synergy between tumour necrosis factor alpha and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation (1988) J Leukoc Biol, 43, pp. 349-356 White, F.A., Bhangoo, S.K., Miller, R.J., Chemokines: integrators of pain and inflammation (2005) Nat Rev Drug Discov, 4, pp. 834-844 Williams, M., Jarvis, M.F., Purinergic and pyrimidinergic receptors as potential drug targets (2000) Biochem Pharmacol, 59, pp. 1173-1185 Yalcin, I., Choucair-Jaafar, N., Benbouzid, M., Tessier, L.H., Muller, A., Hein, L., Freund-Mercier, M.J., Barrot, M., Beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain (2009) Ann Neurol, 65, pp. 218-225 Zhang, X.W., Liu, Q., Thorlacius, H., Inhibition of selectin function and leukocyte rolling protects against dextran sodium sulfate-induced murine colitis (2001) Scand J Gastroenterol, 36, pp. 270-275 Zimmermann, M., Ethical guidelines for investigations of experimental pain in conscious animals (1983) Pain, 16, pp. 109-110